C11orf95-RELA fusions drive oncogenic NF-κB signalling in ependymoma.
about
The NF-κB Pathway and Cancer Stem CellsGenomics, microRNA, epigenetics, and proteomics for future diagnosis, treatment and monitoring response in upper GI cancersThe Similarities and Differences between Intracranial and Spinal Ependymomas : A Review from a Genetic Research PerspectiveAn integrative view on sex differences in brain tumorsDynamic aberrant NF-κB spurs tumorigenesis: a new model encompassing the microenvironmentHippo Pathway in Organ Size Control, Tissue Homeostasis, and CancerMolecular Markers in Low-Grade Glioma-Toward Tumor ReclassificationThe Influenza A Virus Genotype Determines the Antiviral Function of NF-κBCONSERTING: integrating copy-number analysis with structural-variation detection.Telomerase inhibition abolishes the tumorigenicity of pediatric ependymoma tumor-initiating cells.Discovering and understanding oncogenic gene fusions through data intensive computational approachesRecent advances in subtyping tumors of the central nervous system using molecular data.Fluorescence in situ hybridization in surgical pathology: principles and applications.Epistemology of the origin of cancer: a new paradigm.Clinical association analysis of ependymomas and pilocytic astrocytomas reveals elevated FGFR3 and FGFR1 expression in aggressive ependymomas.Molecular Testing of Brain Tumor.Integrating Tenascin-C protein expression and 1q25 copy number status in pediatric intracranial ependymoma prognostication: A new model for risk stratification.ACVR1 mutations in DIPG: lessons learned from FOP.New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETs.C11orf95-RELA fusion present in a primary supratentorial ependymoma and recurrent sarcoma.The ependymal region of the adult human spinal cord differs from other species and shows ependymoma-like featuresCross-Species Genomics Identifies TAF12, NFYC, and RAD54L as Choroid Plexus Carcinoma Oncogenes.The landscape and therapeutic relevance of cancer-associated transcript fusions.Pediatric Brain Tumors: Innovative Genomic Information Is Transforming the Diagnostic and Clinical Landscape.Clinical course and progression-free survival of adult intracranial and spinal ependymoma patients.Cancer susceptibility syndromes in children in the area of broad clinical use of massive parallel sequencing.An in vivo screen identifies ependymoma oncogenes and tumor-suppressor genes.Fusion genes with ALK as recurrent partner in ependymoma-like gliomas: a new brain tumor entity?Whole Exome Sequencing Identifies TSC1/TSC2 Biallelic Loss as the Primary and Sufficient Driver Event for Renal Angiomyolipoma Development.Genetic differences on intracranial versus spinal cord ependymal tumors: a meta-analysis of genetic researches.Phase I study of 5-fluorouracil in children and young adults with recurrent ependymoma.Molecular Classification of Ependymal Tumors across All CNS Compartments, Histopathological Grades, and Age GroupsPreclinical studies of 5-fluoro-2'-deoxycytidine and tetrahydrouridine in pediatric brain tumorsTargeted next-generation sequencing panel (GlioSeq) provides comprehensive genetic profiling of central nervous system tumors.The landscape of fusion transcripts in spitzoid melanoma and biologically indeterminate spitzoid tumors by RNA sequencingPrimary Glial and Neuronal Tumors of the Ovary or Peritoneum: A Clinicopathologic Study of 11 Cases.Genetic alterations in uncommon low-grade neuroepithelial tumors: BRAF, FGFR1, and MYB mutations occur at high frequency and align with morphology.Biology and management of ependymomas.Supratentorial clear cell ependymomas with branching capillaries demonstrate characteristic clinicopathological features and pathological activation of nuclear factor-kappaB signalingChromosome 1q gain and tenascin-C expression are candidate markers to define different risk groups in pediatric posterior fossa ependymoma
P2860
Q26750605-E04B57AF-45DF-4BDC-ADAA-35AF0674C214Q26751068-FD8970B1-5844-4CA4-B60E-F94F440DAB0BQ26766642-C34367D5-9F36-4E43-9E2C-C73A3DF51C24Q26829861-BDD97CAC-A6ED-41C6-A789-7C5A02CBCD0BQ27025321-9D1BA25E-71E3-4EA9-BEE3-376037351E2DQ28269498-F9724D35-990E-4E3A-8DAD-EF61A931C32FQ28383205-29539285-41DA-44F1-8E1C-28AE3B73342FQ28830060-AAC817D3-0806-4338-B09A-C33B8F75A0B4Q30397544-472BBFEB-E920-41C7-9ED3-E07C796E47B4Q30613404-0847E54B-A2D0-45B1-8515-769B3154E766Q31083417-75526964-3326-4DF3-8772-22C6DAB41DFFQ31145092-FB524BB7-F2E6-4E00-B35B-3FD63DBC7BF2Q33593910-21E4A1C6-B84F-47B4-AF15-2F4696AF2C9EQ33631655-594BDAD8-D7C3-4604-B60D-79F8E7AC2B06Q33634701-291E76E8-799E-4A4C-8035-978ACC949E56Q33729693-7ECD210A-0E86-4E27-B2FE-AD681E81CE49Q33803137-650EB003-7FB6-4C85-9265-4892FE420C79Q34134675-AAF0E4E2-A596-4646-8389-3B8D4ABAF610Q34515911-AFCB9D72-458D-4134-9A4E-A5D586CDE9AEQ35450056-3E7B8C60-85F4-43E0-B581-B5F6F90C6CBEQ35604841-CDBACC83-06DA-4EBD-9DA2-3C399C1C230AQ35692614-F097326D-D3F3-4E8D-80C8-FAD0BB92BEB1Q35744353-4757A1E6-D0CD-45F7-A08B-5150ACAC8B46Q35754390-7CE7D8CD-0468-4357-8A92-CD6DF9433F2FQ35788894-90C7E14B-28C6-4001-B14D-315F71B5C3A7Q35894536-9E3B9511-0CD5-4B8A-A042-EE385A7B2069Q35904519-A1A87888-8816-47B4-9EE0-2288FAA11B05Q36082481-268CBA7B-9684-4B81-9FDD-56EB7F2FCA6BQ36095750-C7A0FCDD-9F85-453B-A7C4-BF3576F3556EQ36135966-C1062367-D4FB-4A01-90DB-618523A7F621Q36250758-A5B47A7D-037F-464C-8C2B-072801822CB9Q36461766-BB0C19A3-B3AA-4689-954A-4329F33B8494Q36480084-77F9876F-9A40-4452-B579-E6EE0126EB0DQ36618268-8216DD2F-E6D7-4B8E-993E-6DF67959F136Q36739466-4CCEDD15-3F01-4236-B195-7E6A5DFB82F2Q36892843-5C6D0AD9-5E24-493D-AB84-2AA027AEF5E7Q36900873-B5A86B2F-85EB-438B-B7B6-8BB196D795C7Q36977704-69849AB2-D6D9-402E-BC2A-F7B40429A268Q36977707-C6334C80-5530-487D-B5D7-E92095F07579Q37196135-D8FD9961-68B0-4157-B279-52745E108283
P2860
C11orf95-RELA fusions drive oncogenic NF-κB signalling in ependymoma.
description
2014 nî lūn-bûn
@nan
2014 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
C11orf95-RELA fusions drive oncogenic NF-κB signalling in ependymoma.
@ast
C11orf95-RELA fusions drive oncogenic NF-κB signalling in ependymoma.
@en
type
label
C11orf95-RELA fusions drive oncogenic NF-κB signalling in ependymoma.
@ast
C11orf95-RELA fusions drive oncogenic NF-κB signalling in ependymoma.
@en
prefLabel
C11orf95-RELA fusions drive oncogenic NF-κB signalling in ependymoma.
@ast
C11orf95-RELA fusions drive oncogenic NF-κB signalling in ependymoma.
@en
P2093
P2860
P50
P356
P1433
P1476
C11orf95-RELA fusions drive oncogenic NF-κB signalling in ependymoma.
@en
P2093
Amar Gajjar
Amy A Smith
Bhavin Vadodaria
Chandanamali Punchihewa
Charles Lu
David Finkelstein
David W Ellison
David Zhao
Donald Yergeau
P2860
P2888
P304
P356
10.1038/NATURE13109
P407
P577
2014-02-19T00:00:00Z
P5875
P6179
1050781394